Trial participants reported positive changes in how they handled food-focused social situations
Approximately 40% of patients remain at 1.0 or 1.7 mg as their maintenance dose rather than escalating to 2.4 mg
Participants who had already lost weight through diet and exercise continued losing additional weight with tirzepatide, demonstrating that the drug adds meaningful benefit even when combined with non-pharmacological approaches
Chantalat, E., Valera, C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., Arnal, F., & Lenfant, F
Post-procedure plan: short protection phase , then eccentric loading , stretching , and manual therapy if indicated
Reconstitution & Handling in Research Settings Both BPC 157 and TB 500 are supplied in lyophilized (freeze-dried) powder form for research purposes